Investment Management

Equity Investment to Biotechnology Companies

Our investment management business is primarily in growth equity and late stage biotechnology companies for which we have deep understanding and the ability to leverage significant support. Our equity investment teams focus on biotech companies with large unmet medical needs, strong science, well differentiated technologies, and high-quality clinical development programs. We are passionate about using our deep institutional knowledge of and extensive contacts across the healthcare and life sciences industry to create efficiency and improve outcomes in the equity investments to biotechnology companies.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More
If you would like to get in touch with us, please click here. Contact us